Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial

INTRODUCTION: Upfront surgeries are not beneficial to most patients with pancreatic cancer. Therefore, more emphasis has been placed chemoradiotherapy in locally advanced pancreatic cancer recently. Gemcitabine-based regimens or FOLFIRINOX (a chemotherapy regimen including leucovorin, 5-FU, irinotec...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMJ Open
Egile Nagusiak: Zhu, Xiaofei, Ju, Xiaoping, Cao, Fei, Fang, Fang, Qing, Shuiwang, Shen, Yuxin, Jia, Zhen, Cao, Yangsen, Zhang, Huojun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2016
Gaiak:
Oncology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5168617/
https://ncbi.nlm.nih.gov/pubmed/27909037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-013220
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak